Abstract
OBJECTIVE: To evaluate the relationship between serum leptin levels and metabolic syndrome, fasting insulin level and anthropometric index in obese pre-pubertal children.
DESIGN: A cross-sectional study was carried out on obese children.
SUBJECTS: A study was made of 41 obese children (aged 6–9 y) and the same number of non-obese children (control group), matched by age and sex.
METHODS: Body mass index (BMI), waist/hip ratio (WHR) and blood pressure were determined in each child. Serum leptin, glucose, insulin, lipid profile, sex hormone binding globulin (SHBG), plasminogen activator inhibitor-1 (PAI-1), tissue-plasminogen activator (t-PA) and fibrinogen were all measured.
RESULTS: The serum leptin level was significantly higher in obese children (15.47 vs 4.73 ng/ml). In the obese group, leptin showed a positive correlation with BMI (P<0.001), insulin (P<0.001), triglycerides (P<0.05), PAI-1 (P<0.05) and t-PA (P<0.05), and correlated negatively with SHBG (P<0.01), apolipoprotein A-I (P<0.05) and high-density lipoproteins cholesterol (HDL-C) (P<0.05). Corrected for BMI and WHR, leptin (P partial=0.002) is only an independent predictive factor for basal insulin. Using multivariant regression analysis, only insulin (P partial=0.003) and BMI (P partial=0.018) were independent predictive factors for leptin.
CONCLUSION: For this age group, high leptin resistance may be another component of metabolic syndrome, and may be involved in its etiopathogenesis. The involvement of leptin in this syndrome may be indirect, modulating the insulin's action.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Turner RC . The role of obesity in diabetes. Int J Obes Relat Metab Disord 1992; 16 (Suppl 2): S43–S46.
Pi-Sunyer FX . Medical hazards of obesity. Ann Intern Med 1993; 119: 655–660.
Kissebah AH, Freedman DS & Peiris AN . Health risks of obesity. Med Clin North Am 1989; 73: 111–138.
Reaven GM . Role of insulin resistance in human disease. Diabetes 1988; 37: 1595–1607.
Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ & Bauer TL et al . Serum immunoreactive-leptin concentrations in normal weight and obese humans. New Engl J Med 1996; 334: 292–295.
Monti LD, Brambilla P, Stefani I, Caumo A, Magni F, Poma R, Tomasini L, Agostini G, Galli-Kienle M & Cobelli C et al . Insulin regulation of glucose turnover and lipid levels in obese children with fasting normoinsulinaemia. Diabetologia 1995; 38: 739–747.
Caprio S, Bronson M, Sherwin RS, Rife F & Tamborlane WV . Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children. Diabetologia 1996; 39: 1489–1497.
Csabi G, Torok K, Jeges S & Molnar D . Presence of metabolic cardiovascular syndrome in obese children. Eur J Pediatr 2000; 159: 91–94.
Asayama K, Hayashibe H, Dobashi K, Uchida N, Kawada Y & Nakazawa S . Relationships between biochemical abnormalities and anthropometric indices of overweight, adiposity and body fat distribution in Japanese elementary school children. Int J Obes Relat Metab Disord 1995; 19: 253–259.
Wattigney WA, Harsha DW, Srinivasan SR, Webber LS & Berenson GS . Increasing impact of obesity on serum lipids and lipoproteins in young adults. The Bogalusa Heart Study. Arch Intern Med 1991; 151: 2017–2022.
Tokunaga K, Ishikawa K, Sudo H, Matsuzawa Y, Yamamoto A & Tarui S . Serum lipoprotein profile in Japanese obese children. Int J Obes 1982; 6: 399–404.
Gascón F, Valle M, Martos R, Ruz FJ, Ríos R, Montilla P & Cañete R . Sex hormone-binding globulin as a marker for hyperinsulinemia and/or insulin resistance in obese children. Eur J Endocrinol 2000; 143: 85–89.
Valle M, Gascón F, Martos R, Ruz FJ, Bermudo F, Ríos R & Cañete R . Infantile obesity: a situation of atherothrombotic risk? Metabolism 2000; 49: 672–675.
Valle M, Gascón F, Martos R, Ruz FJ, Bermudo F, Morales R & Cañete R . Metabolic cardiovascular syndrome in obese pre-pubertal children: the role of high fasting insulin levels. Metabolism 2002; 51: 423–428.
Kamoda T, Saitoh H, Nakahara S, Izumi I, Hirano T & Matsui A . Serum leptin and insulin concentrations in prepubertal lean, obese and insulin-dependent diabetes mellitus children. Clin Endocrinol 1998; 49: 385–389.
Zimonet P, Hodge A, Nicolson M, Staten M, de Courten M, Moore J, Morawiecki A, Lubina J, Collier G, Alberti G & Dowse G . Serum leptin concentration, obesity, and insulin resistance in Western Samoans: cross sectional study. Br Med J 1996; 313: 965–969.
Cohen B, Novick D & Rubinstein M . Modulation of insulin activities by leptin. Science 1996; 274: 1185–1188.
Shimabukuro M, Koyama K, Chen G, Wang MY, Trieu F, Lee Y, Newgard CB & Unger RH . Direct antidiabetic effects of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci USA 1997; 94: 4637–4641.
Walder K, Filippis A, Clark S, Zimmet P & Collier GR . Leptin inhibits insulin binding in isolated rat adipocytes. J Endocrinol 1997; 155: R5–R7.
Emilsson V, Liu YL, Cawthorne MA, Morton NM & Davenport M . Expression of the functional leptin receptor mRNA in pancreatic islets and direct inhibitory action of leptin on insulin secretion. Diabetes 1997; 46: 313–316.
de Courten M, Zimmet P, Hodge A, Collins V, Nicolson M, Staten M, Dowse G & Alberti KG . Hyperleptinaemia: the missing link in the metabolic syndrome? Diabetic Med 1997; 14: 200–208.
Leyva F, Godsland IF, Ghatei M, Proudler AJ, Aldis S, Walton C, Bloom S & Stevenson JC . Hyperleptinemia as a component of a metabolic syndrome of cardiovascular risk. Arterioscler Thromb Vasc Biol 1998; 18: 928–933.
Zimmat P, Boyko EJ, Collier GR & de Courten M . Etiology of the metabolic syndrome: potential role of insulin resistance, leptin resistance, and other players. Ann NY Acad Sci 1999; 892: 25–44.
Fruehwald-Schultes B, Peters A, Kern W, Beyer J & Pfutzner A . Serum leptin is associated with serum uric acid concentrations in humans. Metabolism 1999; 48: 677–680.
Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A & Sattar N . Plasma leptin and the risk of cardiovascular disease in the West of Scotland Coronary Prevention Study (WOSCOPS). Circulation 2001; 104: 3052–3056.
Hernández M, Castell J, Narvaiza JL, Rincón JM, Ruiz E & Sánchez E . Curvas y tablas de crecimiento. Instituto de Investigación sobre Crecimiento y Desarrollo. Funcación Faustino Orbegozo. Madrid, Ed. Garsi 1988.
Friedewald WT, Levy RI & Fredrickson DS . Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
Krotkiewski M, Björntorp P, Sjöstrom L & Smith U . Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150–1162.
Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, Travia D, Zenti MG, Branzi P, Santi L & Muggeo M . Relationship of uric acid concentration to cardiovascular risk factors in young men. Role of obesity and central fat distribution. The Verona Young Men Atherosclerosis Risk Factors Study. Int J Obes Relat Metab Disord 1996; 20: 975–989.
Ferrannini E, Haffner SM, Mitchell BD & Stern MP . Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 1991; 34: 416–422.
Moussa MA, Shaltout AA, Nkansa-Dwamena D, Mourad M, Al-Sheikh N, Agha N & Galal DO . Association of fasting insulin with serum lipids and blood pressure in Kuwaiti children. Metabolism 1998; 47: 420–424.
Steinberger J . Insulin resistance and cardiovascular risk in the pediatric patient. Prog Pediatr Cardiol 2001; 12: 169–175.
Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K & Olsson T . Leptin is associated with increased risk of myocardial infarction. J Intern Med 1999; 246: 409–418.
De Mitrio V, De Pergola G, Vettor R, Marino R, Sciaraffia M, Pagano C, Scaraggi FA, Di Lorenzo L & Giorgino R . Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women. Metabolism 1999; 48: 960–964.
Sudi KM, Gallistl S, Weinhandl G, Muntean W & Borkenstein MH . Relationship between plasminogen activator inhibitor-1 antigen, leptin, and fat mass in obese children and adolescents. Metabolism 2000; 49: 890–895.
Aizawa-Abe M, Ogawa Y, Masuzaki H, Ebihara K, Satoh N, Iwai H, Matsuoka N, Hayashi T, Hosoda K, Inoue G, Yoshimasa Y & Nakao K . Pathophysiological role of leptin in obesity-related hypertension. J Clin Invest 2000; 105: 1243–1252.
Sheu WH, Lee WJ & Chen YT . High plasma leptin concentrations in hypertensive men but not in hypertensive women. J Hypertens 1999; 17: 1289–1295.
Uckaya G, Ozata M, Sommez A, Kinalp C, Eyileten T, Bingol N, Koc B, Kocabalkan F & Ozdemir IC . Plasma leptin levels strongly correlate with plasma renin activity in patients with essential hypertension. Horm Metab Res 1999; 31: 435–438.
Acknowledgements
This study was supported by grants from the Fondo de Investigación Sanitaria (FIS 183/97), Spanish Ministry of Health and the Andalusian Health Service (44/00). We thank Gabriela de Torres, Consuelo López, Carmen Segura and María Dolores Bonilla for their technical assistance.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Valle, M., Gascón, F., Martos, R. et al. Relationship between high plasma leptin concentrations and metabolic syndrome in obese pre-pubertal children. Int J Obes 27, 13–18 (2003). https://doi.org/10.1038/sj.ijo.0802154
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijo.0802154
Keywords
This article is cited by
-
Metabolic Syndrome in Children and Adolescents: Looking to New Markers
Current Treatment Options in Pediatrics (2021)
-
Circulating leptin levels are associated with adiposity in survivors of childhood brain tumors
Scientific Reports (2020)
-
Genistein treatment improves fracture resistance in obese diabetic mice
BMC Endocrine Disorders (2017)
-
Early-onset obesity dysregulates pulmonary adipocytokine/insulin signaling and induces asthma-like disease in mice
Scientific Reports (2016)
-
Serum leptin is associated with cardiometabolic risk and predicts metabolic syndrome in Taiwanese adults
Cardiovascular Diabetology (2011)